Industry Research Reports

Home > Reports > Medical Care > Global Gastrointestinal Cancer Treatment Market Research Report 2026

Global Gastrointestinal Cancer Treatment Market Research Report 2026

Industry: Medical Care

Published Date: 2026-04-27

Pages: 124 Pages

Report ld: 6652643

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Gastrointestinal Cancer Treatment Market Size(US$)

CAGR 2026-2032

12.6%

Market Size,2032

USD 12,720

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 6,255 million

Market Forecast in 2032(Value)

US$ 12,720 million

CAGR

12.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Gastrointestinal Cancer Treatment market was valued at US$ 5619 million in 2025 and is anticipated to reach US$ 12720 million by 2032, at a CAGR of 12.6% from 2026 to 2032.

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Gastrointestinal Cancer Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gastrointestinal Cancer Treatment. The Gastrointestinal Cancer Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Gastrointestinal Cancer Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Gastrointestinal Cancer Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

By Company

Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy

Segment by Application

Hospitals
Clinics
Research Centers
Others

biaoTi Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Gastrointestinal Cancer Treatment companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Surgery

1.2.3 Targeted Drugs Therapy

1.2.4 Chemo Therapy

1.2.5 Adjuvant Chemotherapy

1.2.6 Radiation Therapy

1.3 Market by Application

1.3.1 Global Gastrointestinal Cancer Treatment Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2021–2032)

2.2 Global Gastrointestinal Cancer Treatment Growth Trends by Region

2.2.1 Global Gastrointestinal Cancer Treatment Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Gastrointestinal Cancer Treatment Historic Market Size by Region (2021–2026)

2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2027–2032)

2.3 Gastrointestinal Cancer Treatment Market Dynamics

2.3.1 Gastrointestinal Cancer Treatment Industry Trends

2.3.2 Gastrointestinal Cancer Treatment Market Drivers

2.3.3 Gastrointestinal Cancer Treatment Market Challenges

2.3.4 Gastrointestinal Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue

3.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2021–2026)

3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2021–2026)

3.2 Global Top Gastrointestinal Cancer Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Gastrointestinal Cancer Treatment Revenue

3.4 Global Gastrointestinal Cancer Treatment Market Concentration Ratio

3.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2025

3.5 Global Key Players of Gastrointestinal Cancer Treatment Head Offices and Areas Served

3.6 Global Key Players of Gastrointestinal Cancer Treatment, Products and Applications

3.7 Global Key Players of Gastrointestinal Cancer Treatment, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Gastrointestinal Cancer Treatment Breakdown Data by Type

4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2021–2026)

4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2027–2032)

5 Gastrointestinal Cancer Treatment Breakdown Data by Application

5.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2021–2026)

5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Gastrointestinal Cancer Treatment Market Size (2021–2032)

6.2 North America Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Gastrointestinal Cancer Treatment Market Size by Country (2021–2026)

6.4 North America Gastrointestinal Cancer Treatment Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gastrointestinal Cancer Treatment Market Size (2021–2032)

7.2 Europe Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Gastrointestinal Cancer Treatment Market Size by Country (2021–2026)

7.4 Europe Gastrointestinal Cancer Treatment Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size (2021–2032)

8.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2021–2026)

8.4 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Gastrointestinal Cancer Treatment Market Size (2021–2032)

9.2 Latin America Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2021–2026)

9.4 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size (2021–2032)

10.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2021–2026)

10.4 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Details

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction

11.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.1.5 Eli Lilly Recent Development

11.2 F. Hoffmann

11.2.1 F. Hoffmann Company Details

11.2.2 F. Hoffmann Business Overview

11.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction

11.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.2.5 F. Hoffmann Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction

11.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.3.5 GlaxoSmithKline Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Gastrointestinal Cancer Treatment Introduction

11.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.4.5 Merck Recent Development

11.5 Novartis AG

11.5.1 Novartis AG Company Details

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction

11.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.5.5 Novartis AG Recent Development

11.6 Otsuka Holdings

11.6.1 Otsuka Holdings Company Details

11.6.2 Otsuka Holdings Business Overview

11.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction

11.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.6.5 Otsuka Holdings Recent Development

11.7 Stryker Corporation

11.7.1 Stryker Corporation Company Details

11.7.2 Stryker Corporation Business Overview

11.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction

11.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.7.5 Stryker Corporation Recent Development

11.8 Boston Scientific Corporation

11.8.1 Boston Scientific Corporation Company Details

11.8.2 Boston Scientific Corporation Business Overview

11.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction

11.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.8.5 Boston Scientific Corporation Recent Development

11.9 Johnson and Johnson

11.9.1 Johnson and Johnson Company Details

11.9.2 Johnson and Johnson Business Overview

11.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction

11.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.9.5 Johnson and Johnson Recent Development

11.10 CONMED Corporation

11.10.1 CONMED Corporation Company Details

11.10.2 CONMED Corporation Business Overview

11.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction

11.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.10.5 CONMED Corporation Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Details

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction

11.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction

11.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.12.5 Pfizer Recent Development

11.13 Celltrion Inc

11.13.1 Celltrion Inc Company Details

11.13.2 Celltrion Inc Business Overview

11.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction

11.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.13.5 Celltrion Inc Recent Development

11.14 Amgen Limited

11.14.1 Amgen Limited Company Details

11.14.2 Amgen Limited Business Overview

11.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction

11.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.14.5 Amgen Limited Recent Development

11.15 Celgene Corporation

11.15.1 Celgene Corporation Company Details

11.15.2 Celgene Corporation Business Overview

11.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction

11.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.15.5 Celgene Corporation Recent Development

11.16 Sanofi

11.16.1 Sanofi Company Details

11.16.2 Sanofi Business Overview

11.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction

11.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.16.5 Sanofi Recent Development

11.17 Mylan N.V.

11.17.1 Mylan N.V. Company Details

11.17.2 Mylan N.V. Business Overview

11.17.3 Mylan N.V. Gastrointestinal Cancer Treatment Introduction

11.17.4 Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.17.5 Mylan N.V. Recent Development

11.18 Samsung Bioepis

11.18.1 Samsung Bioepis Company Details

11.18.2 Samsung Bioepis Business Overview

11.18.3 Samsung Bioepis Gastrointestinal Cancer Treatment Introduction

11.18.4 Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.18.5 Samsung Bioepis Recent Development

11.19 Teva Pharmaceutical Industries Ltd.

11.19.1 Teva Pharmaceutical Industries Ltd. Company Details

11.19.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.19.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Introduction

11.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2021–2026)

11.19.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

Table of Figures

List of Tables

Table 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Surgery

Table 3. Key Players of Targeted Drugs Therapy

Table 4. Key Players of Chemo Therapy

Table 5. Key Players of Adjuvant Chemotherapy

Table 6. Key Players of Radiation Therapy

Table 7. Global Gastrointestinal Cancer Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Gastrointestinal Cancer Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Gastrointestinal Cancer Treatment Market Size by Region (US$ Million), 2021–2026

Table 10. Global Gastrointestinal Cancer Treatment Market Share by Region (2021–2026)

Table 11. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Gastrointestinal Cancer Treatment Market Share by Region (2027–2032)

Table 13. Gastrointestinal Cancer Treatment Market Trends

Table 14. Gastrointestinal Cancer Treatment Market Drivers

Table 15. Gastrointestinal Cancer Treatment Market Challenges

Table 16. Gastrointestinal Cancer Treatment Market Restraints

Table 17. Global Gastrointestinal Cancer Treatment Revenue by Players (US$ Million), 2021–2026

Table 18. Global Gastrointestinal Cancer Treatment Market Share by Players (2021–2026)

Table 19. Global Top Gastrointestinal Cancer Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gastrointestinal Cancer Treatment Revenue, 2025

Table 20. Ranking of Global Top Gastrointestinal Cancer Treatment Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Gastrointestinal Cancer Treatment Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Gastrointestinal Cancer Treatment, Headquarters and Area Served

Table 23. Global Key Players of Gastrointestinal Cancer Treatment, Products and Applications

Table 24. Global Key Players of Gastrointestinal Cancer Treatment, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Gastrointestinal Cancer Treatment Market Size by Type (US$ Million), 2021–2026

Table 27. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2021–2026)

Table 28. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2027–2032)

Table 30. Global Gastrointestinal Cancer Treatment Market Size by Application (US$ Million), 2021–2026

Table 31. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2021–2026)

Table 32. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2027–2032)

Table 34. North America Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2021–2026

Table 36. North America Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Gastrointestinal Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Gastrointestinal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (US$ Million), 2027–2032

Table 49. Eli Lilly Company Details

Table 50. Eli Lilly Business Overview

Table 51. Eli Lilly Gastrointestinal Cancer Treatment Product

Table 52. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 53. Eli Lilly Recent Development

Table 54. F. Hoffmann Company Details

Table 55. F. Hoffmann Business Overview

Table 56. F. Hoffmann Gastrointestinal Cancer Treatment Product

Table 57. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 58. F. Hoffmann Recent Development

Table 59. GlaxoSmithKline Company Details

Table 60. GlaxoSmithKline Business Overview

Table 61. GlaxoSmithKline Gastrointestinal Cancer Treatment Product

Table 62. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 63. GlaxoSmithKline Recent Development

Table 64. Merck Company Details

Table 65. Merck Business Overview

Table 66. Merck Gastrointestinal Cancer Treatment Product

Table 67. Merck Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 68. Merck Recent Development

Table 69. Novartis AG Company Details

Table 70. Novartis AG Business Overview

Table 71. Novartis AG Gastrointestinal Cancer Treatment Product

Table 72. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 73. Novartis AG Recent Development

Table 74. Otsuka Holdings Company Details

Table 75. Otsuka Holdings Business Overview

Table 76. Otsuka Holdings Gastrointestinal Cancer Treatment Product

Table 77. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 78. Otsuka Holdings Recent Development

Table 79. Stryker Corporation Company Details

Table 80. Stryker Corporation Business Overview

Table 81. Stryker Corporation Gastrointestinal Cancer Treatment Product

Table 82. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 83. Stryker Corporation Recent Development

Table 84. Boston Scientific Corporation Company Details

Table 85. Boston Scientific Corporation Business Overview

Table 86. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product

Table 87. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 88. Boston Scientific Corporation Recent Development

Table 89. Johnson and Johnson Company Details

Table 90. Johnson and Johnson Business Overview

Table 91. Johnson and Johnson Gastrointestinal Cancer Treatment Product

Table 92. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 93. Johnson and Johnson Recent Development

Table 94. CONMED Corporation Company Details

Table 95. CONMED Corporation Business Overview

Table 96. CONMED Corporation Gastrointestinal Cancer Treatment Product

Table 97. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 98. CONMED Corporation Recent Development

Table 99. Bristol-Myers Squibb Company Details

Table 100. Bristol-Myers Squibb Business Overview

Table 101. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product

Table 102. Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 103. Bristol-Myers Squibb Recent Development

Table 104. Pfizer Company Details

Table 105. Pfizer Business Overview

Table 106. Pfizer Gastrointestinal Cancer Treatment Product

Table 107. Pfizer Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 108. Pfizer Recent Development

Table 109. Celltrion Inc Company Details

Table 110. Celltrion Inc Business Overview

Table 111. Celltrion Inc Gastrointestinal Cancer Treatment Product

Table 112. Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 113. Celltrion Inc Recent Development

Table 114. Amgen Limited Company Details

Table 115. Amgen Limited Business Overview

Table 116. Amgen Limited Gastrointestinal Cancer Treatment Product

Table 117. Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 118. Amgen Limited Recent Development

Table 119. Celgene Corporation Company Details

Table 120. Celgene Corporation Business Overview

Table 121. Celgene Corporation Gastrointestinal Cancer Treatment Product

Table 122. Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 123. Celgene Corporation Recent Development

Table 124. Sanofi Company Details

Table 125. Sanofi Business Overview

Table 126. Sanofi Gastrointestinal Cancer Treatment Product

Table 127. Sanofi Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 128. Sanofi Recent Development

Table 129. Mylan N.V. Company Details

Table 130. Mylan N.V. Business Overview

Table 131. Mylan N.V. Gastrointestinal Cancer Treatment Product

Table 132. Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 133. Mylan N.V. Recent Development

Table 134. Samsung Bioepis Company Details

Table 135. Samsung Bioepis Business Overview

Table 136. Samsung Bioepis Gastrointestinal Cancer Treatment Product

Table 137. Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 138. Samsung Bioepis Recent Development

Table 139. Teva Pharmaceutical Industries Ltd. Company Details

Table 140. Teva Pharmaceutical Industries Ltd. Business Overview

Table 141. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Product

Table 142. Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (US$ Million), 2021–2026

Table 143. Teva Pharmaceutical Industries Ltd. Recent Development

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

Table 147. Authors List of This Report

List of Figures

Figure 1. Gastrointestinal Cancer Treatment Picture

Figure 2. Global Gastrointestinal Cancer Treatment Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Gastrointestinal Cancer Treatment Market Share by Type: 2025 vs 2032

Figure 4. Surgery Features

Figure 5. Targeted Drugs Therapy Features

Figure 6. Chemo Therapy Features

Figure 7. Adjuvant Chemotherapy Features

Figure 8. Radiation Therapy Features

Figure 9. Global Gastrointestinal Cancer Treatment Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Gastrointestinal Cancer Treatment Market Share by Application: 2025 vs 2032

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Research Centers Case Studies

Figure 14. Others Case Studies

Figure 15. Gastrointestinal Cancer Treatment Report Years Considered

Figure 16. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Gastrointestinal Cancer Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Gastrointestinal Cancer Treatment Market Share by Region: 2025 vs 2032

Figure 19. Global Gastrointestinal Cancer Treatment Market Share by Players in 2025

Figure 20. Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2025

Figure 22. North America Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Gastrointestinal Cancer Treatment Market Share by Country (2021–2032)

Figure 24. United States Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Gastrointestinal Cancer Treatment Market Share by Country (2021–2032)

Figure 28. Germany Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Region (2021–2032)

Figure 36. China Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Gastrointestinal Cancer Treatment Market Share by Country (2021–2032)

Figure 44. Mexico Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Gastrointestinal Cancer Treatment Market Share by Country (2021–2032)

Figure 48. Israel Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Gastrointestinal Cancer Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 52. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 54. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 55. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 56. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 57. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 58. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 59. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 60. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 62. Pfizer Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 63. Celltrion Inc Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 64. Amgen Limited Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 65. Celgene Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 66. Sanofi Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 67. Mylan N.V. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 68. Samsung Bioepis Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 69. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2021–2026)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

Related Reports

Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published Date: 2024-01-24
Pages: 133
USD 3950.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2024
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published Date: 2024-01-31
Pages: 94
USD 2900.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Insights, Forecast to 2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published Date: 2024-04-26
Pages: 118
USD 4900.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2025
The global market for Gastrointestinal Cancer Treatment was valued at US$ 5049 million in the year 2024 and is projected to reach a revised size of US$ 11430 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published Date: 2025-02-27
Pages: 91
USD 2900.00
(Single User License)
Gastrointestinal Cancer Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 122
USD 3950.00
(Single User License)
Global Gastrointestinal Cancer Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gastrointestinal Cancer Treatment market size was US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 108
USD 4250.00
(Single User License)
Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5619 million in 2025 and is projected to reach US$ 12720 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 137
USD 3950.00
(Single User License)

Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published: 2024-01-24
Pages: 133
USD 3950.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2024
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published: 2024-01-31
Pages: 94
USD 2900.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Insights, Forecast to 2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published: 2024-04-26
Pages: 118
USD 4900.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2025
The global market for Gastrointestinal Cancer Treatment was valued at US$ 5049 million in the year 2024 and is projected to reach a revised size of US$ 11430 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published: 2025-02-27
Pages: 91
USD 2900.00 (Single User License)
Gastrointestinal Cancer Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 122
USD 3950.00 (Single User License)
Global Gastrointestinal Cancer Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gastrointestinal Cancer Treatment market size was US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 108
USD 4250.00 (Single User License)
Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5619 million in 2025 and is projected to reach US$ 12720 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-07-14
Pages: 137
USD 3950.00 (Single User License)